CLINICAL_TRIALS
trial_result
· 2019-11-04
Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Summary
Phase 2 trial assessing combination chemotherapy with peripheral stem cell transplantation for metastatic prostate cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED